A PTEN-specific 19-nucleotide sequence, corresponding to the 1065-1083 region (relative to the first nucleotide of the ATG) in the human PTEN transcript (i.e. TCCAGAGGCTAGCAGTTCA and the complementary strand separated by a TCTCTTGAA spacer), was inserted in the mammalian expression vector pSuper.basic (OligoEngine, UK) to obtain pSUPER-ShPten. H1-ShPten cassette from pSUPER-ShPten was then subcloned in pLVTHM vector (kindly provided by D. Trono, EPFL, Switzerland) by replacing the H1 promoter cassette in pLVTHM by the H1-ShPten cassette excised from pSUPER-shPten using standard cloning procedures. All constructs were confirmed by DNA sequencing. Recombinant lentiviruses were produced by transient transfection in 293T cells according to standard protocols 1 . Viral titers ranged between 1 x 10 6 and 5 x 10 6 cell-transducing U per ml as determined by flow cytometric analysis of GFP expression in HeLa cells. HepG2 cells were then transduced with lentiviral vectors at a multiplicity of infection of 20 for 16 h (more than 90% of HepG2 cells were transduced). 1. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vectormediated drug-inducible RNA interference. J Virol 2003;77:8957-61.
